Author

J. Amiaud

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Boutin· 1 shared A. Chantome· 1 shared A. Postec· 1 shared A. Wakkach· 1 shared B. Brounais-Le Royer· 1 shared B. Ory· 1 shared C. Blin-Wakkach· 1 shared C. Hue· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

A. Boutin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Chimeric protein EWS-FLI1 drives cell proliferation in Ewing Sarcoma via overexpression of KCNN1.

M. Dupuy, M. Gueguinou, A. Postec, R. Brion, R. Tesfaye, M. Mullard, L. Regnier, J. Amiaud, M. Potier-Cartereau, A. Chantome, B. Brounais-Le Royer, M. Baud'huin, S. Georges, F. Lamoureux, B. Ory, , F. Verrecchia

This study identifies KCNN1 as a target of EWS-FLI1 and EWS-ERG fusion proteins in Ewing Sarcoma, showing its role in cell proliferation and potential as a therapeutic target.

bioRxiv · Apr 24, 2023 · PreprintCancer Biology

Specific targeting of inflammatory osteoclastogenesis by the probiotic yeast S. boulardii CNCM I-745 reduces bone loss in osteoporosis

M.-B. Madel, J. Halper, L. Ibanez, C. Lozano, M. Rouleau, A. Boutin, R. Pontier-Bres, T. Ciucci, M. Topi, C. Hue, J. Amiaud, S. Iborra, D. Sancho, D. Heymann, H.-J. Garchon, , C. Blin-Wakkach

This study identifies PRRs regulating inflammatory osteoclasts and shows that S. boulardii reduces bone loss by targeting these cells.

bioRxiv · Aug 1, 2022Physiology